Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial
暂无分享,去创建一个
G. Rozycki | K. Inaba | D. Feliciano | K. Laupland | A. Kirkpatrick | J. Salomone | S. Hameed | P. Navsaria | A. Wyrzykowski | E. Dixon | S. Widder | J. Zink | Michael Lowe | Walter Reed Army
[1] K. Ker,et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. , 2011, The Cochrane database of systematic reviews.
[2] Alan D. Lopez,et al. Maternal mortality for 181 countries, 1980–2008: a systematic analysis of progress towards Millennium Development Goal 5 , 2010, The Lancet.
[3] D. Elbourne,et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial , 2010, Trials.
[4] Fiona Lecky,et al. Intracranial bleeding in patients with traumatic brain injury: A prognostic study , 2009, BMC emergency medicine.
[5] I. Roberts,et al. Bmc Pregnancy and Childbirth Open Access Anti-fibrinolytic Agents in Post Partum Haemorrhage: a Systematic Review , 2022 .
[6] M. Kenward,et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.
[7] David A Spiegel,et al. Injuries: the neglected burden in developing countries. , 2009, Bulletin of the World Health Organization.
[8] P. Edwards,et al. BMC Medical Research Methodology BioMed Central , 2008 .
[9] M. Cohen,et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. , 2008, The Journal of trauma.
[10] Ewout Steyerberg,et al. Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients , 2008, BMJ : British Medical Journal.
[11] Salim Yusuf,et al. Specific barriers to the conduct of randomized trials , 2008, Clinical trials.
[12] Juan Lu,et al. Prognostic value of computerized tomography scan characteristics in traumatic brain injury: results from the IMPACT study. , 2007, Journal of neurotrauma.
[13] Rolf Lefering,et al. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. , 2006, The Journal of trauma.
[14] I Roberts,et al. Antifibrinolytic drugs for acute traumatic injury. , 2004, The Cochrane database of systematic reviews.
[15] J. Lawson,et al. Challenges for providing effective hemostasis in surgery and trauma. , 2004, Seminars in hematology.
[16] Lance J. Oyen,et al. Plasma Tranexamic Acid Concentrations During Cardiopulmonary Bypass , 2001, Anesthesia and analgesia.
[17] J. Weckström,et al. Tranexamic Acid Reduces Blood Loss in Total Hip Replacement Surgery , 2000, Anesthesia and analgesia.
[18] R. Maier,et al. Trauma mortality patterns in three nations at different economic levels: implications for global trauma system development. , 1997, The Journal of trauma.
[19] Y. Okada,et al. Enzyme-Controlling Medicines: Introduction , 1997, Seminars in thrombosis and hemostasis.
[20] A Busuttil,et al. The time of death after trauma , 1995, BMJ.
[21] D. V. Van Riper,et al. The Dose‐Response Relationship of Tranexamic Acid , 1995, Anesthesiology.
[22] A. Rodgers,et al. Systematic Underestimation of Treatment Effects as a Result of Diagnostic Test Inaccuracy: Implications for the Interpretation and Design of Thromboprophylaxis Trials , 1995, Thrombosis and Haemostasis.
[23] A. Sauaia,et al. Epidemiology of trauma deaths: a reassessment. , 1993, The Journal of trauma.